Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

844
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
844
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

296
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
296
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

798
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
798
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

267
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
267

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrated immune profiling identifies a coordinated T-cell activation and inflammatory signature in SLE.

Lupus science & medicine·2026
Same author

Fracture risk assessment in early-stage autosomal dominant polycystic kidney disease: a cross-sectional study using FRAX<sup>®</sup>, QFracture<sup>®</sup>, and Garvan models.

BMC nephrology·2026
Same author

Vitamin D3 and Body Composition Association with Graft Function in Long-Term Kidney Transplant Recipients.

International journal of molecular sciences·2026
Same author

Trichological Disorders in Organ Transplant Recipients: Case Report and Literature Review.

Case reports in dermatology·2026
Same author

Higher Serum Omega-3 Polyunsaturated Fatty Acid Content Is Associated with Improved Long-Term Cardiovascular and Renal Outcomes in Patients with Chronic Kidney Disease.

Nutrients·2026
Same author

Primary prevention of skin cancer in patients after kidney transplantation - a literature review.

Cancer treatment and research communications·2026

Related Experiment Video

Updated: Jan 6, 2026

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

17.7K

Viruses in transplantology.

Krzysztof Mucha, Bartosz Foroncewicz, Alicja Dębska-Ślizień

    Polish Archives of Internal Medicine
    |October 9, 2019
    PubMed
    Summary

    Solid organ transplantation (SOT) patients face increased risks from infections, which contribute to cardiovascular disease and cancer. Managing these infections in immunocompromised SOT recipients is a significant clinical challenge.

    More Related Videos

    Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus
    11:18

    Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus

    Published on: May 7, 2012

    13.3K
    Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats
    08:55

    Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats

    Published on: April 15, 2016

    9.9K

    Related Experiment Videos

    Last Updated: Jan 6, 2026

    Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
    08:52

    Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

    Published on: May 27, 2011

    17.7K
    Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus
    11:18

    Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus

    Published on: May 7, 2012

    13.3K
    Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats
    08:55

    Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats

    Published on: April 15, 2016

    9.9K

    Area of Science:

    • Infectious Diseases
    • Transplant Medicine
    • Immunology

    Background:

    • Infections are a major concern for solid organ transplantation (SOT) recipients, contributing to leading causes of mortality such as cardiovascular diseases and malignancies.
    • Immunosuppressive therapy post-SOT compromises immune function, heightening susceptibility to both acute and chronic infections.

    Discussion:

    • Viral infections play a critical role in the pathogenesis of atherosclerosis and are implicated in at least 20% of neoplasms.
    • The management of infections in immunocompromised SOT patients presents unique and complex clinical challenges.

    Key Insights:

    • Infections are a significant and growing threat in modern medicine, particularly in transplantology.
    • Understanding the interplay between immunosuppression, infection, and long-term outcomes in SOT is crucial.

    Outlook:

    • Further research is needed to develop effective strategies for preventing and treating infections in SOT recipients.
    • Continued education and knowledge sharing, like the presented lectures, are vital for advancing care in transplant infectious diseases.